Brief: Genfit Announces Publication In The Journal Of Hepatology On NIS2+
Dec 6 (Reuters) - Genfit SA GNFT.PA :
* GENFIT ANNOUNCES PUBLICATION IN THE JOURNAL OF HEPATOLOGY
ON THE
ACCURATE PERFORMANCE OF NIS2+™ AS A SCREENING TOOL FOR THE
ENROLLMENT OF PATIENTS IN MASH CLINICAL TRIALS
* PAPER PUBLISHED IN JOURNAL OF HEPATOLOGY DEMONSTRATES THAT
NIS2+
TECHNOLOGY COULD SIGNIFICANTLY REDUCE LIVER BIOPSY FAILURE
Source text for Eikon: ID:nGNE678MDy
Further company coverage: GNFT.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com ; +48 58 769 66 00;))
Recent news on Genfit SA
See all newsFrance's Genfit H1 revenue falls due to absence of milestone payments
French and Benelux stocks-Factors to watch on September 15
Brief: Genfit SA - Advances Nangibotide In Phase 2 Clinical Investigation In Aclf
Brief: Euronext Includes Genfit, Inventiva In SBF120 Index; Interparfums, Verallia Excluded
Brief: Genfit March 31 Cash And Cash Equivalents EUR 136.1 Million